bi-4SCAR PSMA/CD70
/ SZGIMI
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
August 25, 2026
PSMA/CD70 Bi-specific CAR-T Cell Therapy
(clinicaltrials.gov)
- P1/2 | N=60 | Terminated | Sponsor: Shenzhen Geno-Immune Medical Institute | Trial completion date: Dec 2030 ➔ Jul 2026 | Recruiting ➔ Terminated | Trial primary completion date: Dec 2026 ➔ Jul 2026
Trial completion date • Trial primary completion date • Trial termination • Oncology • CD70
June 23, 2026
PSMA/CD70 Bi-specific CAR-T Cell Therapy
(clinicaltrials.gov)
- P1/2 | N=60 | Recruiting | Sponsor: Shenzhen Geno-Immune Medical Institute | Trial completion date: Jun 2026 ➔ Dec 2030 | Trial primary completion date: Dec 2025 ➔ Dec 2026
Trial completion date • Trial primary completion date • Oncology • CD70
June 29, 2022
PSMA/CD70 Bi-specific CAR-T Cell Therapy
(clinicaltrials.gov)
- P1/2 | N=60 | Recruiting | Sponsor: Shenzhen Geno-Immune Medical Institute
CAR T-Cell Therapy • New P1/2 trial • Oncology • CD70
1 to 3
Of
3
Go to page
1